Inspection reports obtained by ABC News show a series of quality control issues. Even as shots of the Johnson & Johnson COVID-19 vaccine resume across the country following a recent ...

Emergent BioSolutions is a commercial stage company focused on developing vaccines and therapeutics to protect against public health threats worldwide. The company experienced a steep decline in stock ...

As more Marylanders become eligible to get a COVID-19 vaccine, some are wondering about the supply of the Johnson & Johnson vaccine after a quality control process identified one batch of drug ...

Millions of doses were lost due to quality-control issues, the probe found. Between March 2020 and February 2022, vaccine-maker Emergent BioSolutions was forced to discard or destroy up to 400 million ...

Emergent BioSolutions has faced significant challenges, with its stock price falling sharply since my previous article in July 2024. The company's updated mission focuses on combating health threats ...